Skip to content
  • Last Ranking Update: 23 hours ago
  • Company

Company Rank

42,860

Country Rank

SR Score

2,138

SR Web

2,250

SR Social

0

AesRx is a biopharmaceutical company dedicated to the development of two novel drugs, Aes-103 and Aes-210, which targets orphan diseases.

Acquired by Baxter International on July 09, 2014

Website: https://www.aesrx.com

Founded: January 01, 2008

Social:

 SR Traffic - Month

 Ahrefs

AesRx Competitors

Add Competitor

Startup Industry Description
24Genetics
Pharmaceuticals & Biotechnology DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
MDacne
Healthcare Equipment & Services Treating Acne Was never this Easy - MDAlgorithms developed a Mobile App platform to di ...
BetterHealthcare
Healthcare Equipment & Services A better care experience for all - At BetterHealthcare, our passion is to transform y ...
View more competitors»

AesRx Funding

Add Funding

Date Round Amount Investors
Dec 10, 2013 Debt Financing $ 600,000
May 09, 2013 Debt Financing $ 1,355,150
Jun 30, 2011 Debt Financing $ 1,500,000
View more funding rounds»

AesRx Acquisitions

Add Acquisition

Date Acquired Amount
There are no acquisitions.

AesRx Products

Add Product

Product Stage Description
There are no products.

AesRx Team

Add Team Member

Person Role Period
There are no team members.

AesRx News

Add News

Date Title
There are no news.

AesRx Statistics

Last Week

Rank

SR Score

Likes

Followers



Last Month

Rank

SR Score

Likes

Followers